Human respiratory syncytial virus epidemiology and demographics: Difference between revisions
No edit summary |
m Changes made per Mahshid's request |
||
Line 16: | Line 16: | ||
[[Category:Mononegavirales]] | [[Category:Mononegavirales]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] |
Revision as of 18:03, 18 September 2017
Human respiratory syncytial virus Microchapters |
Differentiating Human Respiratory Syncytial Virus from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Human respiratory syncytial virus epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Human respiratory syncytial virus epidemiology and demographics |
FDA on Human respiratory syncytial virus epidemiology and demographics |
CDC on Human respiratory syncytial virus epidemiology and demographics |
Human respiratory syncytial virus epidemiology and demographics in the news |
Blogs on Human respiratory syncytial virus epidemiology and demographics |
Directions to Hospitals Treating Human respiratory syncytial virus |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Epidemiology and Demographics
Prevalence
In the United States, 60% of infants are infected during their first RSV season, and nearly all children will have been infected with the virus by 2-3 years of age.
Age
RSV causes respiratory tract infections in patients of all ages. It is the major cause of lower respiratory tract infection during infancy and childhood.